Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Fuyan Shi
Baogang Hospital of Inner Mongolia
Baotou
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
175
TOTAL CITATIONS
0
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Safety of the Peroxisome Proliferator-Activated Receptor Pan-Agonist Chiglitazar in Patients with Type 2 Diabetes (CMAP): A 24 Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial
Number of pages: 100
Posted: 21 Aug 2019
Linong Ji
,
Weihong Song
,
Hui Fang
,
Wei Li
,
Jianlin Geng
,
Yangang Wang
,
Lian Guo
,
Hanqing Cai
,
Tao Yang
,
Hongmei Li
,
Gangyi Yang
,
Qifu Li
,
Kuanzhi Liu
,
Shuying Li
,
Yanjun Liu
, Fuyan Shi,
Xinsheng Li
,
Xin Gao
,
Haoming Tian
,
Qiuhe Ji
,
Qing Su
,
Zhiguang Zhou
,
Wenbo Wang
,
Zunhai Zhou
,
Xuejun Li
,
Yancheng Xu
,
Zhiqiang Ning
,
Haixiang Cao
,
Desi Pan
,
He Yao
,
Xianping Lu
and
Wei-Ping Jia
Peking University - Department of Endocrinology and Metabolism, Southern Medical University - Chenzhou No.1 People's Hospital, Tangshan Gongren Hospital, Xuzhou Medical University, Harrison International Peace Hospital, Qingdao University - Affiliated Hospital, China Three Gorges University (CTGU) - College of Medical Science, Jilin University (JLU) - Second Hospital, Jiangsu Province Hospital, China Meitan General Hospital, Chongqing University, Chongqing Medical University - Department of Endocrinology, Hebei Medical University, Tianjin Medical University - General Hospital, Government of the People's Republic of China - 306th Hospital, Baogang Hospital of Inner Mongolia, Cangzhou Central Hospital, Fudan University - Zhongshan Hospital, Sichuan University, Government of the People's Republic of China - Air Force Medical University, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, Central South University - Key Laboratory of Diabetes Immunology, Peking University, Central South University - Second Xiangya Hospital, Xiamen University - First Affiliated Hospital, Wuhan University - Zhongnan Hospital, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd and Shanghai Jiao Tong University (SJTU) - Department of Endocrinology and Metabolism
Downloads
94
(720,278)
View PDF
Download
Abstract:
2.
Immunological and Clinical Immunotherapy Implications of
NLRP3
Mutations in Melanoma
Number of pages: 23
Posted: 15 Oct 2020
Qinghua Wang
,
Juncheng Lyu
, Fuyan Shi,
Yanfeng Ren
,
Qian Mao
,
Yujie Liu
,
Ting Li
,
Xiangchun Li
and
Suzhen Wang
Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Health Statistics, School of Public Health, Weifang Medical University, Baogang Hospital of Inner Mongolia, Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Health Statistics, School of Public Health, Weifang Medical University, Department of Bone and Soft Tissue Tumor, Tianjin Medical University, Tianjin Medical University - National Clinical Research Center for Cancer and Weifang Medical University - Department of Health Statistics
Downloads
81
(796,622)
View PDF
Download
Abstract:
Melanoma, Immunotherapy, NLRP3 mutations, predictive indicator
Feedback